CD32B

Produktanfrage

Klinische Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Indikationen	Klinische Studie
Boserolimab	MK-5890	Phase 2 Clinical	Merck & Co Inc	Solid tumours; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms; Carcinoma, Non-Small-Cell Lung	Details
Varlilumab	CDX-1127	Phase 2 Clinical	Celldex Therapeutics	Lung Neoplasms; Cholangiocarcinoma; Prostatic Neoplasms; Bile Duct Neoplasms; Urologic Neoplasms; Astrocytoma; Burkitt Lymphoma; Lymphoma, Non-Hodgkin; Gallbladder Neoplasms; Lymphoma, T-Cell; Lymphoma, Primary Effusion; Urogenital Neoplasms; Glioma; Leukemia, Lymphocytic, Chronic, B-Cell; Melanoma; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Leukemia, T-Cell; Large intestine neoplasm; Central Nervous System Lymphoma; Skin Neoplasms; Solid tumours; Kidney Neoplasms; Head and Neck Neoplasms; Lymphoma, B-Cell, Marginal Zone; Ovarian Neoplasms; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Lymphomatoid Granulomatosis; Lymphoma, Large B-Cell, Diffuse; Lymphoma, B-Cell; Glioblastoma; Neoplasms; Kidney Diseases; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Urologic Diseases; Oligodendroglioma; Lymphoma, Mantle-Cell; Plasmablastic Lymphoma	Details
GEN-1053	BNT-313; GEN-1053	Phase 2 Clinical	Genmab A/S	Solid tumours	Details
LOR-S03	CDX-527	Phase 1 Clinical	Celldex Therapeutics	Ovarian Neoplasms; Solid tumours; Liver Neoplasms; Head and Neck Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Esophageal Neoplasms; Neoplasms; Microsatellite instability-high cancer; Urinary Bladder Neoplasms; Cholangiocarcinoma; Breast Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung	Details
Anti-CD27 monoclonal antibody (Aduro Biotech)	BION-1402	Phase 1 Clinical	Aduro Biotech Inc	Neoplasms	Details